Memory Rehabilitation Strategies in Patients With Multiple Sclerosis
NCT ID: NCT05462678
Last Updated: 2022-07-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2018-09-01
2021-11-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
For these purposes, three homogeneous groups of 20 patients each will be enrolled, diagnosed with MS according to Mc Donald's criteria revisited by Polman (2011). The study will be divided into an initial clinical, cognitive, emotional, quality of life and functional self-perception (T0) assessment. Subsequently, the patients assigned to the three conditions will be provided with the pre-established rehabilitation treatments for a total duration of 12 weeks; at the end, each patient will undergo an overall re-evaluation (T1). Finally, a further overall reassessment will be carried out after 6 months, aimed at follow-up monitoring (T2).
Statistical analyzes will be of two types:
Within Group (aimed at assessing any improvement in the cognitive performance of each group of patients by comparing the assessments at T0 with those at T1 and T2); Between Group (aimed at comparing the results obtained by each group with those of the other 2 groups at T0, T1, and T2).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Who Benefits Most From Cognitive Rehabilitation for Multiple Sclerosis?
NCT05509426
Effects of Telerehabilitation on Brain Network Connectivity
NCT06278818
Telerehabilitation in Mild Cognitive Impairment
NCT03486704
Unraveling Active Ingredients of Neurorehabilitation: Investigating Cortical Activity During Task-oriented Exercises
NCT06826638
Cognitive Rehabilitation of Deficits in Patients With Multiple Sclerosis
NCT06964581
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Motor Rehabilitation
the third group carried out a traditional MR training.
Motor Rehabilitation
Each patient performed two weekly sessions45 minutes each, for a total of 12 weeks.
Cognitive Rehabilitation
the first group carried out a training of CR by three memory modules of the Rehacom program (http://www.emsmedical.net).
Cognitive Rehabilitation
Each patient performed two weekly sessions of 45 minutes each, for 12 weeks
Combined Training
the second group followed a mixed training program with the use of the version of the verbal memory module of the Rehacom program combined with the MR training.
Combined Rehabilitation
Each patient performed one session per week (45 minutes) of CR and one session per week of traditional MR training for 12 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive Rehabilitation
Each patient performed two weekly sessions of 45 minutes each, for 12 weeks
Combined Rehabilitation
Each patient performed one session per week (45 minutes) of CR and one session per week of traditional MR training for 12 weeks.
Motor Rehabilitation
Each patient performed two weekly sessions45 minutes each, for a total of 12 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* RRMS or SPMS phenotype.
* Language Italian mother tongue.
* EDSS score \<6.0
Exclusion Criteria
* Clinical relapses in the three months prior to enrollment
* Severe mental illness
* Psychiatric disorders severe enough to interfere with cognitive functioning
* Medications Steroid therapy in the 3 months prior to enrollment
* Motor limitations Upper limb dysfunction (paralysis or tremor) that does not allow to hold the PC mouse
* Sensory limitations Visual acuity impaired enough to not allow reading of the instructions to the various tests
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
I.R.C.C.S. Fondazione Santa Lucia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ugo Nocentini, MD
Role: STUDY_DIRECTOR
I.R.C.C.S. "Santa Lucia" Foundation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Santa Lucia Foundation I.R.C.C.S.
Roma, Rm, Italy
I.R.C.C.S. "Santa Lucia" Foundation
Rome, , Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Argento O, Piacentini C, Bossa M, Caltagirone C, Santamato A, Saraceni V, Nocentini U. Motor, cognitive, and combined rehabilitation approaches on MS patients' cognitive impairment. Neurol Sci. 2023 Mar;44(3):1109-1118. doi: 10.1007/s10072-022-06552-4. Epub 2022 Dec 21.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CE/PROG.698
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.